Synopsys Inc (SNPS) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock has negative technical indicators, mixed analyst ratings, and weak financial performance in the latest quarter. While there are some positive catalysts, such as the partnership with Arm and Congress buying activity, the overall sentiment and growth outlook suggest holding rather than buying at this time.
The technical indicators for SNPS are bearish. The MACD is negatively expanding, RSI is neutral at 28.026, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with the next support at 395.305.

Synopsys' partnership with Arm to develop the AGI CPU for AI workloads in data centers.
Elliott Investment Management's acquisition of a multibillion-dollar stake, indicating confidence in operational improvements.
Congress members have shown positive sentiment with recent purchases of SNPS stock.
Hedge funds are selling, with a 427.09% increase in selling activity last quarter.
Analysts have downgraded the stock, citing slow EDA industry growth, muted IP revenue growth, and geopolitical uncertainties.
Financial performance in Q1 2026 shows declining net income (-78.03% YoY), EPS (-82.01% YoY), and gross margin (-17.38% YoY).
In Q1 2026, revenue increased by 65.52% YoY to $2.41 billion. However, net income dropped by 78.03% YoY, EPS fell by 82.01% YoY, and gross margin decreased by 17.38% YoY. These results indicate significant profitability challenges despite revenue growth.
Analysts have downgraded Synopsys recently. Morgan Stanley downgraded the stock to Equal Weight with a price target of $480, citing decelerating EDA growth and limited visibility on profitability. Piper Sandler lowered the price target to $430, citing muted IP revenue growth. HSBC downgraded the stock to Hold with a $455 price target, citing fiscal 2026 as a transition year with uncertainties in the EDA business.